April 27 (SeeNews) - Bulgarian drug maker Unipharm [BUL:59X] said on Friday that its non-consolidated net profit rose to 708,000 levs ($437,200/362,000 euro) in the first quarter of 2018 from 351,000 levs in the like period of last year.